Literature DB >> 27587806

Complete Genome Sequences of Four Enterohemolysin-Positive (ehxA) Enterocyte Effacement-Negative Shiga Toxin-Producing Escherichia coli Strains.

Sandra C Lorenz1, Michael L Kotewicz2, Maria Hoffmann3, Narjol Gonzalez-Escalona3, Markus Fischer4, Julie A Kase3.   

Abstract

Shiga toxin-producing Escherichia coli (STEC) strains are important foodborne pathogens associated with human disease. Most disease-associated STEC strains carry the locus of enterocyte effacement (LEE); however, regularly LEE-negative STEC strains are recovered from ill patients. Few reference sequences are available for these isolate types. Here, we report here the complete genome sequences for four LEE-negative STEC strains.
Copyright © 2016 Lorenz et al.

Entities:  

Year:  2016        PMID: 27587806      PMCID: PMC5009963          DOI: 10.1128/genomeA.00846-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Shiga toxin-producing Escherichia coli (STEC) strains are major foodborne pathogens that can cause mild/bloody diarrhea and life-threatening hemolytic-uremic syndrome (HUS). To date, hundreds of STEC serotypes have been implicated in human disease, with O157:H7 being the most predominant (1). While many STEC strains associated with severe disease possess the locus of enterocyte effacement (LEE) pathogenicity island and often harbor a large EHEC virulence plasmid carrying the enterohemolysin-encoding gene, ehxA (2–4), sporadically, LEE-negative STEC strains are recovered from severely ill individuals (5, 6). However, only a few complete reference sequences are available for those STEC strains; thus, we sequenced the complete genomes of four ehxA-positive LEE-negative STEC strains isolated from foods. Genomic DNA from each strain was isolated from overnight cultures, according to the DNeasy blood and tissue kit (Qiagen, Inc., Valencia, CA) instructions, and the DNA templates were sheared to ≥10 kbp utilizing g-TUBEs (Covaris, Inc., Woburn, MA). Genomic libraries were prepared according to the PacBio 10-kbp insert library protocol using the DNA template prep kit 1.0 and were additionally size-selected with the BluePippin size selection system (Sage Science, Inc., Beverly, MA). Libraries were sequenced on the Pacific Biosciences RS II sequencer (PacBio, Menlo Park, CA) using a P4-C2 chemistry kit on ≥3 single-molecule real-time (SMRT) cells with a 180-min collection protocol. Sequencing reads were de novo assembled with the PacBio Hierarchical Genome Assembly Process 3 (HGAP3.0)/Quiver software package. The resulting assemblies were confirmed with optical maps generated with 30-fold coverage on the Argus Mapping Station, according to the OpGen protocol (OpGen, Inc, Gaithersburg, MD). The closed genomes were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/), and Ridom SeqSphere+ (Ridom GmbH, Münster, Germany) was used for in silico multilocus sequence type (MLST) analysis and to determine the presence of virulence genes. The closed chromosomes of these STEC strains varied in size from 5.2 to 5.5 Mb, with an average G+C content of 50.7%, similar to those results found in other STEC strains (7). These STEC strains belonged to three sequence types (ST), and all carried one exceptionally large >200-kb virulence plasmid (8) (Table 1). Although these strains were isolated from foods and belong to serogroups that are rarely implicated in human disease (1), in silico analysis identified the enterotoxin-encoding genes sta1 and astA, both associated with the development of diarrhea (9). Furthermore, two strains carried the highly HUS-associated stx2a variant, one carried stx1a, and one carried stx2g; the role of stx2g in human pathogenicity remains to be elucidated (10). Additionally, these STEC strains carry genes encoding K88 fimbriae, long polar fimbriae (Lpf), the Iha adhesin, and/or the metalloprotease StcE (Table 1), which presumably enable these STEC strains to colonize the human gut (11–13). Moreover, all carry the glutamate decarboxylase gene gad, enabling these organisms to survive gastric acidity (14).
TABLE 1

Metadata of STEC strains and presence of virulence genes, as identified by in silico analysis

StrainSerotypeSourceSize (bp)G+C content (%)STVirulence factors and other genetic featuresa
Accession no.
stxeaeehxAihasta1astAK88issgadlpfAstcE
CFSAN004178O36:H14Alfalfa sprouts5,498,45350.611762g+++CP015229
213,84745.8++CP012498
CFSAN004179O136:H16Bagged lettuce5,213,99850.83291a+++CP013662
242,18747.0+++++CP012501
CFSAN004180O168:H8bLettuce5,286,55850.77182a++++CP015228
225,29246.3++++CP012500
CFSAN004181O168:H8Ground beef5,233,45950.87182a+++CP013663
223,95246.3++++CP012499

stx, Shiga toxin variant; eae, intimin; iha, IrgA homologue adhesin; sta1, heat-stable enterotoxin; astA, enteroaggregative heat-stable enterotoxin; K88, fimbriae; iss, increased serum survival; gad, glutamate decarboxylase; lpfA, long polar fimbriae; stcE, metalloprotease.

H-type identified in silico, initially reported as O168:HNT.

Metadata of STEC strains and presence of virulence genes, as identified by in silico analysis stx, Shiga toxin variant; eae, intimin; iha, IrgA homologue adhesin; sta1, heat-stable enterotoxin; astA, enteroaggregative heat-stable enterotoxin; K88, fimbriae; iss, increased serum survival; gad, glutamate decarboxylase; lpfA, long polar fimbriae; stcE, metalloprotease. H-type identified in silico, initially reported as O168:HNT. Trace-back analysis is crucial during investigations of foodborne illness outbreaks. The data provided can aid in future efforts to identify the source of infection when matching clinical, food, and environmental isolates. The availability of complete genome sequences will further contribute to the ongoing investigation of genetic differences among various pathogenic E. coli strains.

Accession number(s).

The closed and annotated chromosome and plasmid sequences were deposited in GenBank and are listed in Table 1.
  14 in total

1.  Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Authors:  Søren Persson; Katharina E P Olsen; Steen Ethelberg; Flemming Scheutz
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

2.  Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli.

Authors:  Stephen Doughty; Joan Sloan; Vicki Bennett-Wood; Marcus Robertson; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.

Authors:  Thomas E Grys; Matthew B Siegel; Wyndham W Lathem; Rodney A Welch
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Control of acid resistance in Escherichia coli.

Authors:  M P Castanie-Cornet; T A Penfound; D Smith; J F Elliott; J W Foster
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

5.  Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.

Authors:  A W Paton; M C Woodrow; R M Doyle; J A Lanser; J C Paton
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Attachment of human and pig (K88) enterotoxigenic Escherichia coli strains to either human or porcine small intestinal cells.

Authors:  C F Deneke; K McGowan; A D Larson; S L Gorbach
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Virulence factors and phenotypical traits of verotoxigenic strains of Escherichia coli isolated from human patients in Germany.

Authors:  L Beutin; S Aleksic; S Zimmermann; K Gleier
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

Review 9.  Pathogenomics of the virulence plasmids of Escherichia coli.

Authors:  Timothy J Johnson; Lisa K Nolan
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 10.  Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C.

Authors:  Philipp R Weiglmeier; Paul Rösch; Hanna Berkner
Journal:  Toxins (Basel)       Date:  2010-08-26       Impact factor: 4.546

View more
  5 in total

1.  Plasmids from Shiga Toxin-Producing Escherichia coli Strains with Rare Enterohemolysin Gene (ehxA) Subtypes Reveal Pathogenicity Potential and Display a Novel Evolutionary Path.

Authors:  Sandra C Lorenz; Steven R Monday; Maria Hoffmann; Markus Fischer; Julie A Kase
Journal:  Appl Environ Microbiol       Date:  2016-10-14       Impact factor: 4.792

2.  Draft Genome Sequence of Five Shiga Toxin-Producing Escherichia coli Strains Isolated from Wild Deer in Japan.

Authors:  Hiroshi Asakura; Tetsuya Ikeda; Shiori Yamamoto; Hidenori Kabeya; Hiromu Sugiyama; Shinji Takai
Journal:  Genome Announc       Date:  2017-03-02

3.  Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017.

Authors:  Narjol González-Escalona; Julie Ann Kase
Journal:  PLoS One       Date:  2019-04-01       Impact factor: 3.240

4.  Nanopore sequencing for fast determination of plasmids, phages, virulence markers, and antimicrobial resistance genes in Shiga toxin-producing Escherichia coli.

Authors:  Narjol González-Escalona; Marc A Allard; Eric W Brown; Shashi Sharma; Maria Hoffmann
Journal:  PLoS One       Date:  2019-07-30       Impact factor: 3.240

5.  Standardized phylogenetic and molecular evolutionary analysis applied to species across the microbial tree of life.

Authors:  Migun Shakya; Sanaa A Ahmed; Karen W Davenport; Mark C Flynn; Chien-Chi Lo; Patrick S G Chain
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.